Cargando…
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and he...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270763/ https://www.ncbi.nlm.nih.gov/pubmed/35804351 http://dx.doi.org/10.1186/s12933-022-01562-0 |
_version_ | 1784744536451317760 |
---|---|
author | Meziani, Sara Ferrannini, Giulia Bjerre, Mette Hansen, Troels K. Ritsinger, Viveca Norhammar, Anna Gyberg, Viveca Näsman, Per Rydén, Lars Mellbin, Linda G. |
author_facet | Meziani, Sara Ferrannini, Giulia Bjerre, Mette Hansen, Troels K. Ritsinger, Viveca Norhammar, Anna Gyberg, Viveca Näsman, Per Rydén, Lars Mellbin, Linda G. |
author_sort | Meziani, Sara |
collection | PubMed |
description | BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and healthy controls and between subgroups with different glucose tolerance status, and (ii) to investigate the relation between MBL and future cardiovascular events. METHODS: MBL levels were assessed at discharge and after 3 months in 161 AMI patients without any previously known glucose perturbations and in 183 age- and gender-matched controls from the Glucose metabolism in patients with Acute Myocardial Infarction (GAMI) study. Participants were classified as having dysglycaemia, i.e. type 2 diabetes or impaired glucose tolerance, or not by an oral glucose tolerance test. The primary outcome was a composite of cardiovascular events comprising cardiovascular death, AMI, stroke or severe heart failure during 11 years of follow-up. Total and cardiovascular mortality served as secondary outcomes. RESULTS: At hospital discharge patients had higher MBL levels (median 1246 μg/L) than three months later (median 575 μg/L; p < 0.01), the latter did not significantly differ from those in the controls (801 μg/L; p = 0.47). MBL levels were not affected by dysglycaemia either in patients or controls. Independent of glycaemic state, increasing MBL levels did not predict any of the studied outcomes in patients. In unadjusted analyses increasing MBL levels predicted cardiovascular events (hazard ratio HR: 1.67, 95% confidence interval CI 1.06–2.64) and total mortality (HR 1.53, 95% CI 1.12–2.10) in the control group. However, this did not remain in adjusted analyses. CONCLUSIONS: Patients had higher MBL levels than controls during the hospital phase of AMI, supporting the assumption that elevated MBL reflects acute stress. MBL was not found to be independently associated with cardiovascular prognosis in patients with AMI regardless of glucose state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01562-0. |
format | Online Article Text |
id | pubmed-9270763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92707632022-07-10 Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort Meziani, Sara Ferrannini, Giulia Bjerre, Mette Hansen, Troels K. Ritsinger, Viveca Norhammar, Anna Gyberg, Viveca Näsman, Per Rydén, Lars Mellbin, Linda G. Cardiovasc Diabetol Research BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and healthy controls and between subgroups with different glucose tolerance status, and (ii) to investigate the relation between MBL and future cardiovascular events. METHODS: MBL levels were assessed at discharge and after 3 months in 161 AMI patients without any previously known glucose perturbations and in 183 age- and gender-matched controls from the Glucose metabolism in patients with Acute Myocardial Infarction (GAMI) study. Participants were classified as having dysglycaemia, i.e. type 2 diabetes or impaired glucose tolerance, or not by an oral glucose tolerance test. The primary outcome was a composite of cardiovascular events comprising cardiovascular death, AMI, stroke or severe heart failure during 11 years of follow-up. Total and cardiovascular mortality served as secondary outcomes. RESULTS: At hospital discharge patients had higher MBL levels (median 1246 μg/L) than three months later (median 575 μg/L; p < 0.01), the latter did not significantly differ from those in the controls (801 μg/L; p = 0.47). MBL levels were not affected by dysglycaemia either in patients or controls. Independent of glycaemic state, increasing MBL levels did not predict any of the studied outcomes in patients. In unadjusted analyses increasing MBL levels predicted cardiovascular events (hazard ratio HR: 1.67, 95% confidence interval CI 1.06–2.64) and total mortality (HR 1.53, 95% CI 1.12–2.10) in the control group. However, this did not remain in adjusted analyses. CONCLUSIONS: Patients had higher MBL levels than controls during the hospital phase of AMI, supporting the assumption that elevated MBL reflects acute stress. MBL was not found to be independently associated with cardiovascular prognosis in patients with AMI regardless of glucose state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01562-0. BioMed Central 2022-07-08 /pmc/articles/PMC9270763/ /pubmed/35804351 http://dx.doi.org/10.1186/s12933-022-01562-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Meziani, Sara Ferrannini, Giulia Bjerre, Mette Hansen, Troels K. Ritsinger, Viveca Norhammar, Anna Gyberg, Viveca Näsman, Per Rydén, Lars Mellbin, Linda G. Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title | Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title_full | Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title_fullStr | Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title_full_unstemmed | Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title_short | Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort |
title_sort | mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. a report from the gami cohort |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270763/ https://www.ncbi.nlm.nih.gov/pubmed/35804351 http://dx.doi.org/10.1186/s12933-022-01562-0 |
work_keys_str_mv | AT mezianisara mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT ferranninigiulia mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT bjerremette mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT hansentroelsk mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT ritsingerviveca mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT norhammaranna mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT gybergviveca mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT nasmanper mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT rydenlars mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort AT mellbinlindag mannosebindinglectindoesnotexplainthedismalprognosisafteranacutecoronaryeventindysglycaemicpatientsareportfromthegamicohort |